A high level of PLK4 expression in the TCGA dataset was associated with shorter disease-specific survival (DSS) among pan-glioma and LGG patients, as well as shorter progression-free survival (PFS) among these patients (Supplementary Figures 2M–R). This evidence concerns the gene PLK4 and glioma.